Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapies
一项针对对标准疗法无效的不可切除的局部晚期或转移性实体瘤患者的sacituzumab tirumotecan 1/2期研究结果
期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-025-01705-2
Ouyang, Quchang; Rodon, Jordi; Liang, Yan; Wu, Xinhong; Li, Qun; Song, Lihua; Yan, Min; Tong, Zhongsheng; Liu, YunPeng; Wainberg, Zev A; Wang, Ying; Geng, Cuizhi; Ulahannan, Susanna V; Yu, Guohua; Sharma, Manish R; Wang, Xiang; Wang, Judy S; Spira, Alexander; Zhao, Weihong; Sanborn, Rachel E; Cheng, Ying; Wang, Xian; Liu, Gesha; Li, Yaling; Ge, Junyou; Chartash, Elliot; Akala, Omobolaji O; Yin, Yongmei